EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Antiplatelet therapy for treatment of coronary artery disease in older patients

Quentin Fischer, Vincent Pham, Gabriel Seret, Pierre Brami, Fabien Picard, Olivier Varenne

Archives of Cardiovascular Diseases · 2024

DOI: 10.1016/j.acvd.2024.02.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Cardiovascular Diseases, 2024. Verfasst von Quentin Fischer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service de cardiologie, hôpital Cochin, université Paris Cité, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Coronary Artery Disease, Hemorrhage, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary artery disease in older patients is more frequently diffuse and complex, and is often treated by percutaneous coronary intervention on top of medical therapy. There are currently no specific recommendations for antiplatelet therapy in patients aged≥75 years. Aspirin remains pivotal, and is still indicated as a long-term treatment after percutaneous coronary intervention. In addition, a P2Y12 inhibitor is administered for 6-12 months according to clinical presentation. Age is a minor bleeding risk factor, but because older patients often have several co-morbidities, they are considered as having a high bleeding risk according to different scoring systems. This increased bleeding risk has resulted in different therapeutic strategies for antithrombotic treatment after percutaneous coronary intervention; these include short dual antiplatelet therapy, a switch from potent to less potent antiplatelet therapy or single antiplatelet therapy with a P2Y12 inhibitor instead of aspirin, among others. A patient-centred approach, taking into account health status, functional ability, frailty, cognitive skills, bleeding and ischaemic risks and patient preference, is essential when caring for older adults with coronary artery disease. The present review focuses on the knowledge base, specificities of antiplatelet therapies, a balance between haemorrhagic and ischaemic risk, strategies for antiplatelet therapy and directions for future investigation pertaining to coronary artery disease in older patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsCoronary Artery DiseaseHemorrhagePercutaneous Coronary InterventionHumansAgedRisk FactorsTreatment OutcomeAge FactorsRisk AssessmentAged, 80 and overMaleClinical Decision-MakingFemaleDual Anti-Platelet Therapy

Stichwörter der Autor:innen

AnticoagulationAntiplatelet therapyHigh bleeding riskOlder patients

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Service de cardiologie, hôpital Cochin, université Paris Cité, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
  • Service de cardiologie, hôpital Cochin, université Paris Cité, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. Electronic address: olivier.varenne@aphp.fr.

Zitieren

APA

Fischer, Q., Pham, V., Seret, G., Brami, P., Picard, F., & Varenne, O. (2024). Antiplatelet therapy for treatment of coronary artery disease in older patients. Archives of Cardiovascular Diseases. https://doi.org/10.1016/j.acvd.2024.02.008

Vancouver

Fischer Q, Pham V, Seret G, Brami P, Picard F, Varenne O. Antiplatelet therapy for treatment of coronary artery disease in older patients. Archives of Cardiovascular Diseases. 2024. doi:10.1016/j.acvd.2024.02.008

BibTeX
@article{Fischer2024,
  author = {Fischer, Quentin and Pham, Vincent and Seret, Gabriel and Brami, Pierre and Picard, Fabien and Varenne, Olivier},
  title = {Antiplatelet therapy for treatment of coronary artery disease in older patients},
  journal = {Archives of Cardiovascular Diseases},
  year = {2024},
  doi = {10.1016/j.acvd.2024.02.008}
}
Kostenlos starten →